Solesence, Inc. (SLSN) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Solesence, Inc. (SLSN) stock forecast summary
Our AI ranks Solesence, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Solesence, Inc. is a small-cap company with a market capitalization of $70M. It ranks number 9 by market capitalization among the 16 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for SLSN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SLSN included.
Follow SLSN freeSLSN price chart and AI forecast
How SLSN ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Solesence, Inc. (SLSN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
Valuation & Market
| Metric | SLSN | Rank |
|---|---|---|
| Market Cap | $70M | 9/16 |
| P/B Ratio | 5.32x | 4/13 |
| EPS | $-0.02 | – |
| Book Value/Share | $0.19 | – |
| Revenue/Share | $0.78 | – |
Profitability & Margins
| Metric | SLSN | Rank |
|---|---|---|
| ROE | -14.3% | 9/13 |
| ROA | -4.0% | 9/16 |
| ROIC | -4.8% | 10/12 |
| Gross Margin | 26.9% | 12/14 |
| Operating Margin | -1.8% | 11/15 |
| Net Margin | -3.4% | 8/15 |
| EBT Margin | -4.0% | 9/15 |
| Tax Rate | -13.7% | – |
Financial Health
| Metric | SLSN | Rank |
|---|---|---|
| Current Ratio | 0.97x | 14/16 |
| Quick Ratio | 0.47x | 15/16 |
| D/E Ratio | 2.53x | 3/14 |
| Financial Leverage | 3.53x | 3/14 |
| Interest Coverage | 0.4x | 8/13 |
| Working Capital | -$740K | 16/16 |
Cash Flow
| Metric | SLSN | Rank |
|---|---|---|
| Operating Cash Flow | $1M | 10/17 |
Operational Efficiency
| Metric | SLSN | Rank |
|---|---|---|
| Asset Turnover | 1.19x | 5/14 |
| Receivables Turnover | 5.9x | 11/12 |
| Inventory Turnover | 3.1x | 6/13 |
| Fixed Assets Turnover | 3.7x | 13/13 |
| Days Sales Outstanding | 62 days | 2/12 |
| Days Inventory | 117 days | 7/13 |
| Payables Period | 45 days | 9/12 |
| Cash Conversion Cycle | 134 days | 3/11 |
Income Statement
| Metric | SLSN | Rank |
|---|---|---|
| Total Revenue | $55M | 8/14 |
| Operating Income | $0.00M | 8/16 |
| Net Income | -$1M | 10/16 |
| R&D Expense | $4M | 3/5 |
| SG&A Expense | $12M | 9/12 |
| Cost of Goods Sold | $40M | 9/15 |
Dividend & Shareholder Information
| Metric | SLSN | Rank |
|---|---|---|
| Shares Outstanding | 71M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $25M | 54.4% of assets |
| Cash & Short-term Investments | $1M | 2.3% of assets |
| Accounts Receivable | $9M | 20.1% of assets |
| Inventory | $13M | 27.9% of assets |
| Total Liabilities | $33M | 71.7% of assets |
| Short-term Debt | $21M | 45.3% of assets |
SLSN quarterly financials and insider trading
Solesence, Inc. (SLSN) industry peers
Companies classified under the same SEC industry code as Solesence, Inc. (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| SLSN Solesence, Inc. | ▲ | $70M |
| CL Colgate Palmolive Co | ▼ | $71.71B |
| EL Estee Lauder Companies Inc | ▼ | $36.08B |
| KVUE Kenvue Inc. | ▶ | $34.11B |
| ELF E.L.F. Beauty, Inc. | ▼ | $6.38B |
| IPAR Interparfums Inc | ▼ | $3.65B |
| COTY Coty Inc. | ▲ | $2.60B |
| EPC Edgewell Personal Care Co | ▼ | $1.31B |
| WALD Waldencast Plc | ▲ | $97M |
| SHFH Scientist Home Future Health Ltd | ▼ | $40M |
| AXIL Axil Brands, Inc. | ▶ | $40M |
| UG United Guardian Inc | ▲ | $32M |
| DQWS Dswiss Inc | ▶ | $17M |
| CABR Caring Brands, Inc. | ▲ | $14M |
| BNKK Bonk, Inc. | ▶ | $10M |
| YCBD Cbdmd, Inc. | ▲ | $4M |
| HLN Haleon Plc | ▼ | N/A |
| KARX Karbon-X Corp. | ▼ | N/A |
| ODD Oddity Tech Ltd | ▶ | N/A |
Where SLSN sits on the market map
Solesence, Inc. (SLSN) stock news
Loading...
Solesence, Inc. (SLSN) stock forecast FAQ
What is the Solesence, Inc. (SLSN) stock forecast?
Our AI ranks Solesence, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Solesence, Inc. stock predictions?
A per-ticker accuracy statistic for SLSN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Solesence, Inc. forecasts updated?
Solesence, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Solesence, Inc.'s industry peers?
19 issuers in our coverage, SLSN included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.